Another Potential Benefit of Neoadjuvant Therapy in Pancreatic Cancer: Reduction in Postoperative Readmission Rates Mashaal DhirChandrakanth Are Global Health Services Research 02 January 2021 Pages: 1871 - 1873
A Tool for Patient-Focused Care Regarding Neoadjuvant Chemotherapy for Intrahepatic Cholangiocarcinoma Katherine S. CoolsEvan S. Glazer Hepatobiliary Tumors 08 January 2021 Pages: 1874 - 1875
TACE or TARE for Unresectable Neuroendocrine Liver Metastases: Can we Finally Start to Focus on Value? Charles R. Scoggins Hepatobiliary Tumors 28 January 2021 Pages: 1876 - 1877
Electronic Patient-Reported Outcomes After Thoracic Surgery: Toward Better Remote Management of Perioperative Symptoms Cecilia PompiliEthan BaschGita N. Mody Thoracic Oncology 21 January 2021 Pages: 1878 - 1879
Is It Time to Add Tumor Regression Grade into the ypN Category? Yin-Kai Chao Thoracic Oncology 03 January 2021 Pages: 1880 - 1881
Editorial Comment on: MicroRNA-593-3p Expression in Peritoneal Lavage Fluid as a Prognostic Marker for Pancreatic Cancer Patients Undergoing Staging Laparoscopy Takehiko Yokobori Pancreatic Tumors 28 November 2020 Pages: 1882 - 1883
Multimodality Therapy in Operable Pancreatic Cancer: Should We Sequence Surgery Last? Jashodeep DattaNipun B. Merchant Pancreatic Tumors 16 January 2021 Pages: 1884 - 1886
ASO Editorial: Nodal Status as a Clinical Tool in the Treatment of Pancreatic Cancer Marianna V. PapageorgeTeviah E. Sachs Pancreatic Tumors 16 January 2021 Pages: 1887 - 1888
The Suggested Importance of PBRM1 Mutation in Predicting Postoperative Recurrence of Localized Clear Cell Renal Cell Carcinoma Hanan Goldberg Urologic Oncology 08 February 2021 Pages: 1889 - 1891
Global Forum of Cancer Surgeons: Support for the Brazilian Society of Surgical Oncology Journey towards Implementation of Cytoreductive Surgery/Hyperthermic Intraperitoneal Chemotherapy in Brazil Alexandre Ferreira OliveiraClaudio Almeida QuadrosChandrakanth Are Global Health Services Research 18 January 2021 Pages: 1892 - 1895
Neoadjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma is Associated with Lower Post-Pancreatectomy Readmission Rates: A Population-Based Cohort Study Sivesh K. KamarajahSamer A. NaffoujeFadi S. Dahdaleh Global Health Services Research 04 January 2021 Pages: 1896 - 1905
ASO Author Reflections: Is Neoadjuvant Chemotherapy Associated with Acceptable Short-Term Outcomes for Pancreatic Cancer? Sivesh K. KamarajahFadi Dahdaleh ASO Author Reflections 02 January 2021 Pages: 1906 - 1907
Direct Comparison of In-Person Versus Virtual Interviews for Complex General Surgical Oncology Fellowship in the COVID-19 Era Monica M. GrovaSean J. DonohueDavid W. Ollila Health Services Research and Global Oncology 26 November 2020 Pages: 1908 - 1915
ASO Author Reflections: The Impact of Virtual Interviews for Complex General Surgical Oncology Fellowship Monica M. GrovaDavid W. Ollila ASO Author Reflections 07 January 2021 Pages: 1916 - 1917
Race/Ethnicity and County-Level Social Vulnerability Impact Hospice Utilization Among Patients Undergoing Cancer Surgery Alizeh AbbasJ. Madison HyerTimothy M. Pawlik Health Services Research and Global Oncology 14 October 2020 Pages: 1918 - 1926
ASO Author Reflections: How Does Social Vulnerability Impact Hospice Utilization Among Patients Undergoing Cancer Surgery? Alizeh AbbasTimothy M. Pawlik ASO Author Reflections 09 October 2020 Pages: 1927 - 1928
Disparities in Presentation at Time of Hepatocellular Carcinoma Diagnosis: A United States Safety-Net Collaborative Study Joshua P. KronenfeldEmily L. RyonNeha Goel Health Services Research and Global Oncology 25 September 2020 Pages: 1929 - 1936
ASO Author Reflections: Access to Care and Screening Inequities for Patients At Risk for Hepatocellular Carcinoma Joshua P. KronenfeldNeha Goel ASO Author Reflections 24 September 2020 Pages: 1937 - 1938
Neoadjuvant Chemotherapy for Intrahepatic Cholangiocarcinoma: A Propensity Score Survival Analysis Supporting Use in Patients with High-Risk Disease Ovie UtuamaJennifer B. PermuthDaniel A. Anaya Global Health Services Research 07 January 2021 Pages: 1939 - 1949
Chemoembolization Versus Radioembolization for Neuroendocrine Liver Metastases: A Meta-analysis Comparing Clinical Outcomes Lisa NgoAhmed ElnahlaMary Killackey Hepatobiliary Tumors 03 January 2021 Pages: 1950 - 1958
The Impact of Modern Chemotherapy and Chemotherapy-Associated Liver Injuries (CALI) on Liver Function: Value of 99mTc-Labelled-Mebrofenin SPECT-Hepatobiliary Scintigraphy Stéphanie TruantClio BailletFrançois-René Pruvot Hepatobiliary Tumors 24 August 2020 Pages: 1959 - 1969
Tumor Burden Dictates Prognosis Among Patients Undergoing Resection of Intrahepatic Cholangiocarcinoma: A Tool to Guide Post-Resection Adjuvant Chemotherapy? Diamantis I. TsilimigrasJ. Madison HyerTimothy M. Pawlik Hepatobiliary Tumors 01 December 2020 Pages: 1970 - 1978
ASO Author Reflections: Tumor Burden in Intrahepatic Cholangiocarcinoma Diamantis I. TsilimigrasTimothy M. Pawlik ASO Author Reflections 03 January 2021 Pages: 1979 - 1980
ASO Visual Abstract: Tumor Burden Dictates Prognosis Among Patients Undergoing Resection of Intrahepatic Cholangiocarcinoma: A Tool to Guide Post-Resection Adjuvant Chemotherapy? Diamantis I. TsilimigrasTimothy M. Pawlik ASO Visual Abstract 01 January 2021 Pages: 1981 - 1981
Differences in Liver Parenchyma are Measurable with CT Radiomics at Initial Colon Resection in Patients that Develop Hepatic Metastases from Stage II/III Colon Cancer John M. CreasyKristen M. CunananAmber L. Simpson Hepatobiliary Tumors 20 September 2020 Pages: 1982 - 1989
Oncologic Reappraisal of Bile Duct Resection for Middle-Third Cholangiocarcinoma Kosuke JikeiTomoki Ebatathe Nagoya Surgical Oncology Group Hepatobiliary Tumors 22 September 2020 Pages: 1990 - 1999
ASO Author Reflections: Bile Duct Resection—Is It Beneficial for Distal Cholangiocarcinoma? Tomoki EbataKosuke JikeiTakashi Mizuno ASO Author Reflections 22 October 2020 Pages: 2000 - 2000
Stratification of Postoperative Prognosis by Invasive Tumor Thickness in Perihilar Cholangiocarcinoma Mitsunobu ObaYoshitsugu NakanishiSatoshi Hirano Hepatobiliary Tumors 10 October 2020 Pages: 2001 - 2009
ASO Author Reflections: Can Invasive Tumor Thickness Stratify the Postoperative Prognosis of Perihilar Cholangiocarcinoma? Yoshitsugu NakanishiMitsunobu ObaSatoshi Hirano ASO Author Reflections 15 September 2020 Pages: 2010 - 2011
Safety and Oncological Benefit of Hepatopancreatoduodenectomy for Advanced Extrahepatic Cholangiocarcinoma with Horizontal Tumor Spread: Shinshu University Experience Akira ShimizuHiroaki MotoyamaYuji Soejima Hepatobiliary Tumors 12 October 2020 Pages: 2012 - 2025
ASO Author Reflections: Is Major Hepatopancreatoduodenectomy Beneficial for Patients with Advanced and Widespread Extrahepatic Cholangiocarcinoma? Akira ShimizuYuji Soejima ASO Author Reflections 21 October 2020 Pages: 2026 - 2027
Staged Double Hepatectomy, Double Total Vascular Exclusion, and Double Venous Reconstruction by Peritoneal Patches in One Patient with Colorectal Liver Metastases Safi DokmakBĂ©atrice AussilhouOlivier Soubrane Hepatobiliary Tumors 23 September 2020 Pages: 2028 - 2029
Total Laparoscopic Resection of Hilar Cholangiocarcinoma Type 3b: Applying a Parachute Technique for Hepaticojejunostomy Robert SucherUwe ScheuermannDaniel Seehofer Hepatobiliary Tumors Open access 30 September 2020 Pages: 2030 - 2034
ASO Author Reflections: Hepatobiliary Surgeons are Spurred to Implement Totally Minimally Invasive Techniques for Perihilar Cholangiocarcinoma Surgery Robert SucherDaniel Seehofer ASO Author Reflections Open access 01 October 2020 Pages: 2035 - 2036
Landmark Trials in the Surgical Management of Mesothelioma Taylor KantorElliot Wakeam Thoracic Oncology 31 January 2021 Pages: 2037 - 2047
Clinicopathological Significance of Pathologic Complete Lymph Node Regression After Neoadjuvant Chemoradiotherapy in Esophageal Squamous Cell Carcinoma Po-Kuei HsuYi-Chen YehHan-Shui Hsu Thoracic Oncology 20 November 2020 Pages: 2048 - 2058
Comparison of Inflammation-Based Prognostic Scores Associated with the Prognostic Impact of Adenocarcinoma of Esophagogastric Junction and Upper Gastric Cancer Kensuke KudouYuichiro NakashimaMasaki Mori Thoracic Oncology 13 July 2020 Pages: 2059 - 2067
Patient Selection of Sublobar Resection Using Visual Evaluation of Positron-Emission Tomography (PET) for Early-Stage Lung Adenocarcinoma Atsushi KagimotoYasuhiro TsutaniMorihito Okada Thoracic Oncology 18 September 2020 Pages: 2068 - 2075
ASO Author Reflections: Usefulness of Visual Evaluation of PET in Predicting Prognosis after Lung Resection for Early-Stage Lung Adenocarcinoma and Selecting Candidates for Sublobar Resection Atsushi KagimotoYasuhiro TsutaniMorihito Okada ASO Author Reflections 23 September 2020 Pages: 2076 - 2077
Tumor Maximum Area May Determine the Survival Outcomes of Patients with Thymic Epithelial Tumors Dong TianHaruhiko ShiiyaJun Nakajima Thoracic Oncology 19 September 2020 Pages: 2078 - 2085
ASO Author Reflections: Tumor Maximum Area is Better for Representing Tumor Size in Thymic Epithelial Tumors Dong TianHao-Ji YanJun Nakajima ASO Author Reflections 18 September 2020 Pages: 2086 - 2087
Characterization of Extracapsular Lymph Node Involvement and Its Clinicopathological Characteristics in Stage II–IIIA Lung Adenocarcinoma Donglai ChenQifeng DingYongsheng Zhang Thoracic Oncology 04 October 2020 Pages: 2088 - 2098
ASO Author Reflections: Old Song, New Sung—Extracapsular Extension in Lung Cancer in the Era of Eighth-Edition N Classification Donglai ChenQifeng DingYongbing Chen ASO Author Reflections 22 September 2020 Pages: 2099 - 2100
Verification of the Optimal Interval Before Esophagectomy After Preoperative Neoadjuvant Chemoradiotherapy for Locally Advanced Thoracic Esophageal Cancer Akiyuki WakitaSatoru MotoyamaYoshihiro Minamiya Thoracic Oncology 13 October 2020 Pages: 2101 - 2110
The Landmark Series: Neoadjuvant Chemotherapy for Triple-Negative and HER2-Positive Breast Cancer Roberto A. Leon-FerreTina J. HiekenJudy C. Boughey Breast Oncology 23 January 2021 Pages: 2111 - 2119
The Landmark Series: Breast Conservation Trials (including oncoplastic breast surgery) Julie A. MargenthalerJill R. DietzAbhishek Chatterjee Breast Oncology 31 January 2021 Pages: 2120 - 2127
The Effect of Hospital Volume on Outcomes of Patients with Occult Breast Cancer Camille C. BaumruckerSamantha R. SpringDido Franceschi Breast Oncology 10 September 2020 Pages: 2128 - 2135
ASO Author Reflections: Hospital Volume, Cancer Outcomes and Access to Specialized Care Camille C. BaumruckerFrancis I. Macedo ASO Author Reflections 22 September 2020 Pages: 2136 - 2137
Prospective Multicenter Study Validate a Prediction Model for Surgery Uptake Among Women with Atypical Breast Lesions Catherine UzanChafika MazouniStefan Michiels Breast Oncology 12 September 2020 Pages: 2138 - 2145
Treatment Patterns and Outcomes of Women with Breast Cancer and Supraclavicular Nodal Metastases Nina P. TamirisaYi RenRachel A. Greenup Breast Oncology 18 September 2020 Pages: 2146 - 2154